Skip to Content Facebook Feature Image

Designed for What's Next: ESR Unveils Innovations at IFA 2026

Business

Designed for What's Next: ESR Unveils Innovations at IFA 2026
Business

Business

Designed for What's Next: ESR Unveils Innovations at IFA 2026

2026-08-27 15:00 Last Updated At:15:15

Innovations in screen protection, durable materials, and next-generation charging demonstrate how ESR applies thoughtful innovation to create better technology experiences

BERLIN, Aug. 27, 2026 /PRNewswire/ -- ESR, a global tech accessories brand trusted by more than 130 million users worldwide, today announced it will showcase its latest charging, protection, and productivity innovations at IFA 2026, taking place Sept. 4–8, 2026, at Messe Berlin, Germany, Booth H3.2-121.

Under its "Designed for What's Next" philosophy, ESR is creating technology that helps people move through their day with greater confidence, freedom, and ease. From premium new materials and independently tested anti-yellowing technology to advanced screen protection, actively cooled Qi2 25W wireless charging, and compact high-power charging solutions, ESR's innovations are designed to keep important digital devices protected, powered, and ready for whatever comes next.

"Great technology experiences often come down to details that are easy to overlook: how a case feels in your hand, how clear it remains over time, trust in how well a screen is protected, or concern about how much heat you feel while charging," said Tim Wu, CEO of ESR. "'Designed for What's Next' is about paying attention to those everyday concerns and asking how we can make them better. At IFA 2026, we're excited to show how thoughtful design, material innovation, and engineering can come together and turn those insights into meaningful product improvements people care about."

Protection Solutions

A Premium Material Experience

Expanding the possibilities of protective smartphone case design, ESR will showcase the new Atelier Case, its first vegan leather case for iPhone, bringing a more refined look and feel to its protective case lineup without giving up the practical features people love about ESR. Made with silicone-based vegan leather pioneered in luxury car interiors, the new case is designed for people who want the premium look and soft feel of leather paired with a finish that resists stains, wear, and fading.

Long-Lasting Clarity on Display

ESR continues to advance its anti-yellowing technology to help transparent protective cases stay clear longer. This technology has been validated through SGS-certified accelerated UV aging tests designed to simulate demanding real-world conditions, including extreme UV exposure, high temperatures, and repeated day-and-night cycles. On display will be test results that demonstrate yellowing resistance equivalent to 5.5 months of real-world exposure, helping preserve the original look of devices for longer.

Advanced Glass for Stronger Screen Protection

ESR is also showcasing advances in screen protection by combining rigorous impact testing with high-performance glass materials. ESR Lab testing has resulted in up to 10x impact absorption, while Accessory Glass by Corning™ provides up to 2x better scratch resistance compared with other screen protector glass. Together, these technologies address two of the most common risks to smartphone displays—drops and scratches.

Charging Solutions

Faster, Cooler Charging

ESR will also demonstrate how the company is addressing charger-related issues such as high temperatures generated during wireless charging, the need for fast charging capabilities, and the inconvenience of cumbersome power adapters and tangled wires while traveling.

Building on ESR's advances in actively cooled wireless charging, the latest generation of CryoBoost® technology combines Qi2 25W wireless charging with active cooling to deliver a faster, cooler charging experience in a slimmer charger.

For users who want faster charging and fewer loose cables in their bags, ESR is also showcasing a compact charging solution with an integrated retractable cable that delivers up to 60W fast charging. An extended braided cable provides additional reach and flexibility while enhancing durability for everyday use. The result is a compact power solution designed for easy use in the office, at home, on the commute, and while traveling.

Experience ESR at IFA 2026

IFA 2026 takes place Sept. 4–8, 2026, at Messe Berlin in Berlin, Germany. Visitors, media, and industry partners can experience ESR's latest digital device protection and charging innovations at Booth H3.2-121.

ESR will also host media events in New York and Tokyo on Sept. 15.

Discover more about ESR's latest innovations on Amazon or ESR's official site.

About ESR: Trusted for 17 Years

Founded in 2009, ESR is a global tech brand trusted by over 130 million consumers worldwide. We design tech accessories for smart devices to enhance everyday tech experiences. We're on a mission to make tech easier to use—developing products that seamlessly integrate into daily life, helping people live with greater ease and efficiency.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Designed for What's Next: ESR Unveils Innovations at IFA 2026

Designed for What's Next: ESR Unveils Innovations at IFA 2026

  • Provides solutions for analyzing brain atrophy and white matter hyperintensities, as well as monitoring side effects associated with Alzheimer's disease treatments
  • Secures a key reference site at a U.S. medical institution specializing in neurological disorders, accelerating product adoption across major healthcare institutions in North America

SEOUL, South Korea, Aug. 27, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a supply agreement with Elevate Clinic in the United States for Neurophet AQUA and Neurophet AQUA AD Plus.

Based in Texas, Elevate Clinic is a medical institution specializing in neurological disorders and operates at six major cities in the state. In particular, the clinic is recognized for its integrated care system for patients with traumatic brain injury (TBI) and neurological disorders.

TBI is associated with a substantial patient population and significant burden on healthcare professionals in the United States, making the accurate detection of changes in brain volume and microhemorrhages resulting from brain injury important. Neurophet AQUA's brain volumetry and atrophy analysis capabilities, along with Neurophet AQUA AD Plus's microhemorrhage detection capabilities, can also be applied to brain imaging analysis for patients with TBI.

Neurophet AQUA is an AI-powered brain neurodegeneration imaging analysis software that rapidly performs quantitative analysis of patients' brain magnetic resonance imaging (MRI) scans to assess brain atrophy and white matter hyperintensities (WMHs). It quantifies brain atrophy and WMHs associated with neurodegenerative diseases, including Alzheimer's disease and vascular dementia, and provides customized analysis reports for clinicians.

Neurophet AQUA AD Plus is a comprehensive brain imaging analysis solution that provides the capabilities required throughout the prescription process for Alzheimer's disease treatments. Using AI-powered brain MRI analysis, the software can automatically analyze the location and number of hypointense lesions associated with cerebral microhemorrhages and superficial siderosis, as well as hyperintense lesions associated with cerebral edema.

The supply agreement is significant as it establishes a foundation for the clinical use of Neurophet's AI-powered brain imaging analysis solutions at a U.S. medical institution specializing in neurological disorders. Neurophet plans to expand clinical adoption across regional hospitals in the United States by leveraging Elevate Clinic as a reference site specializing in neurological disorders, thereby accelerating its business expansion in the U.S. market.

"Neurological disorders and TBI share commonalities from a brain imaging analysis perspective," said a representative from Elevate Clinic. "We expect that Neurophet's solutions will enable us to more precisely assess the brain condition of patients with TBI and support the delivery of more effective care."

"By supplying Neurophet's key products to Elevate Clinic in the United States, we are expanding our touchpoints with customers in the global market," said Jake Junkil Been, Co-CEO of Neurophet. "We will continue to accelerate the adoption of our products across major medical institutions throughout North America."

About Neurophet

Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.

Major products include brain MRI analysis software "Neurophet AQUA", PET Image Quantitative Analysis Software "Neurophet SCALE PET", Brain imaging treatment planning software for electric and magnetic brain stimulation "Neurophet tES/TMS LAB", Alzheimer's Disease treatment prescription and monitoring software "Neurophet AQUA AD" for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software "Neurophet AQUA MS".

Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain's health and pioneer solutions for brain diseases with AI technology.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market

Neurophet Supplies 'Neurophet AQUA' and 'Neurophet AQUA AD Plus' to Elevate Clinic in the U.S., Expanding Its Presence in the U.S. Brain Disorders Market

Recommended Articles